Alemtuzumab mediates the CD39+ T-regulatory cell response via CD23+ macrophages.
Immunol Cell Biol
; 99(5): 521-531, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-33306219
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukocytes, Mononuclear
/
T-Lymphocytes, Regulatory
Limits:
Humans
Language:
En
Journal:
Immunol Cell Biol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: